SM-07883

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSM-07883
Drug Alias NameSM-07883
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDual-specificity tyrosine-phosphorylation regulated kinase 1A inhibitors
TargetsDual-specificity tyrosine-phosphorylation regulated kinase 1A
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiosplice Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiosplice Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A